EVP and CFO of Boston Scientific Corp (30-Year Financial, Insider Trades) Daniel J. Brennan (insider trades) sold 20,463 shares of BSX on 02/13/2020 at an average price of $42.03 a share. The total sale was $860,060.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. Boston Scientific Corp has a market cap of $58.79 billion; its shares were traded at around $42.18 with a P/E ratio of 12.66 and P/S ratio of 5.72. Boston Scientific Corp had annual average EBITDA growth of 37.70% over the past five years. GuruFocus has detected 1 severe warning sign with Boston Scientific Corp. .
CFO Recent Trades:
- EVP and CFO Daniel J. Brennan sold 20,463 shares of BSX stock on 02/13/2020 at the average price of $42.03. The price of the stock has increased by 0.36% since.
Directors and Officers Recent Trades:
- SVP, Manuf & Sup Chn John Bradley Sorenson sold 7,500 shares of BSX stock on 02/10/2020 at the average price of $42.48. The price of the stock has decreased by 0.71% since.
- EVP,Pres MedSurg David A Pierce sold 2,150 shares of BSX stock on 02/03/2020 at the average price of $42.17. The price of the stock has increased by 0.02% since.
- SVP & Pres, Neuromodulation Maulik Nanavaty sold 9,623 shares of BSX stock on 02/03/2020 at the average price of $42.17. The price of the stock has increased by 0.02% since.
- SVP&Pres, Periph Intervent Jeffrey B. Mirviss sold 23,077 shares of BSX stock on 01/17/2020 at the average price of $44. The price of the stock has decreased by 4.14% since.
For the complete insider trading history of BSX, click here
.
